Trial · NCT01782326
Adverse events702
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 702
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | CONSTIPATION | Gastrointestinal disorders | QVA149 | 19 | 1,678 | |
| other | CONSTIPATION | Gastrointestinal disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 17 | 1,680 | |
| other | DIARRHOEA | Gastrointestinal disorders | QVA149 | 19 | 1,678 | |
| other | DIARRHOEA | Gastrointestinal disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 24 | 1,680 | |
| other | DYSPEPSIA | Gastrointestinal disorders | QVA149 | 18 | 1,678 | |
| other | DYSPEPSIA | Gastrointestinal disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 9 | 1,680 | |
| other | GASTRITIS | Gastrointestinal disorders | QVA149 | 10 | 1,678 | |
| other | GASTRITIS | Gastrointestinal disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 20 | 1,680 | |
| other | NON-CARDIAC CHEST PAIN | General disorders | QVA149 | 20 | 1,678 | |
| other | NON-CARDIAC CHEST PAIN | General disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 11 | 1,680 | |
| other | OEDEMA PERIPHERAL | General disorders | QVA149 | 26 | 1,678 | |
| other | OEDEMA PERIPHERAL | General disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 13 | 1,680 | |
| other | PYREXIA | General disorders | QVA149 | 17 | 1,678 | |
| other | PYREXIA | General disorders | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 27 | 1,680 | |
| other | BRONCHITIS | Infections and infestations | QVA149 | 29 | 1,678 | |
| other | BRONCHITIS | Infections and infestations | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 41 | 1,680 | |
| other | GASTROENTERITIS | Infections and infestations | QVA149 | 10 | 1,678 | |
| other | GASTROENTERITIS | Infections and infestations | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 18 | 1,680 | |
| other | INFLUENZA | Infections and infestations | QVA149 | 34 | 1,678 | |
| other | INFLUENZA | Infections and infestations | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 55 | 1,680 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01782326/events